Analysis Regulatory

FDA's 510(k) transfer Q&A: what holders and buyers should check before a deal closes

New FDA question-and-answer guidance covers when a buyer of a 510(k) clearance needs no new submission and when the original submission number must be used.

VigiEye editorial · Fri 20 Nov 2026

What happened

On 19 November 2026, FDA published a question-and-answer guidance on transferring a 510(k) clearance between holders. Our records list the publication under FDA CBER. The document addresses common questions that arise when a 510(k) is sold or transferred. Two points stand out: when a new holder does not need to file a fresh submission, and when the original submission number must be used.

The records do not say whether the document is draft or final, whether it replaces earlier material, or what it says on each question. This analysis therefore sticks to the framing the record gives and does not guess at the detail. Teams should read the full text before acting on it.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Sources this analysis is based on

Written by VigiEye's editorial system with AI assistance (model claude-sonnet-5-5) strictly from the official records listed above. It can contain errors: check the sources before acting. Not legal, medical or investment advice.

More analysis & opinionAll →